
Combination antiretroviral therapy is an important development in the management of HIV infection. AZT with ddC is the first such combination to be approved for clinical use. Several issues remain, however, including the precise clinical benefit and toxicity of combination therapy, its effect on drug resistance, and the development of ever more effective therapeutic strategies.
Acquired Immunodeficiency Syndrome, Zalcitabine, Drug Resistance, Microbial, HIV Infections, Antiviral Agents, Didanosine, HIV-1, Drug Evaluation, Humans, Drug Therapy, Combination, Zidovudine
Acquired Immunodeficiency Syndrome, Zalcitabine, Drug Resistance, Microbial, HIV Infections, Antiviral Agents, Didanosine, HIV-1, Drug Evaluation, Humans, Drug Therapy, Combination, Zidovudine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
